Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemia

Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemia - Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008539

Enrollment

Registered

2012-07-26

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension and dyslipidemia

Interventions

Intervention by Drug combination therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients during current therapy with antihypertensive agent`amlodipine` and lipid-lowering agent`statin` tehrapy are eligible.

Exclusion criteria

Exclusion criteria: Patients without written imformed consent

Design outcomes

Primary

Measure	Time frame
Blood pressure and LDL-Cholesterol	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026